https://stagin.astx.co.uk/astex-pharmaceuticals-and-otsuka-announce-results-of-the-phase-3-ascertain-study-of-the-novel-oral-cedazuridine-and-decitabine-fixed-dose-combination-astx727-in-patients-with-myelodysplastic-syndrom/